changing hearts, minds, and the addiction treatment industry
Our Boulder Vision
Our Recovery Community
Policy & Advocacy
Research & Education
Articles tagged:
DEA
Policy & Advocacy
When the Public Health Emergency Does(n't?) End
The COVID-era PHE made SUD care accessible in a profound new way. But that could all change once the PHE expires. Boulder has been preparing to ensure continuity of care for our current and future patients and is actively advocating for better regulations to help all people in need of addiction care.
Ben Maclean
General Counsel
Policy & Advocacy
My Birthday Trip
Dave Lerman, Boulder's CTO, details how a personal experience helped him see a need for more support and funding for studies into the potential of psychedelics.
David Lerman
Chief Technology Officer
Policy & Advocacy
The Ways We Regulate Stigma into Law
Ben MacLean, Boulder's General Counsel, explains how laws and regulations can fight against patients with SUDs and stand in the way of better treatment options.
Ben Maclean
General Counsel
Our Boulder Vision
The Rewarding Truth of Prescribing Suboxone
Alyson Smith, Boulder Care’s Medical Director, shares how rewarding working with SUD patients has been for her and how urgent the need is for more clinicians to do the same.
Alyson Smith, MD
Former Medical Director